The Prescription: 1st October Issue
PSM INDIA Capsules National Injections Drug Laws & Policy Injections Global Injections Pharma Injections PSM PillDRUG DOPES UpComing Events Editor’s Emulsion FAQ Laughter Dose Blog Addict
News Archive

Pooja Khaitan

It was truly overwhelming to see the response of pharmacists across India who sent in their applications for the best pharmacist award. I take this opportunity in congratulating each one of them who came forward to apply for the same. Your contribution to society is invalauble. Our current issue bears the names of the winners. Incase your name doesn’t reflect we wish you all the best for next year. Continue your deidcated efforts.

PSM India has been diligently spreading the message on quality healthcare. Attending the PSM interchange at Washington D.C. for all 5 years, our founder head , Mr.Misra shares his experience. PSM India capsules of this issue also features Mr. Misra’s presentation at the Interchange.

Is it safe to buy medicines over the counter without a prescription? If yes, then which ones? Read our frequently asked questions section to know more on OTC drugs.

Happy Reading !
Stay Safe. Stay Healthy !

Pooja Khaitan
Chief Editor , The PRESCRIPTION Partnership for Safe Medicines India.


“Oral health is integral to overall health and globally it is a challenging issue. Due to prevalence and incidence, oral diseases pose a major threat to public health. Most people are ignorant of the significance of oral health and its impact on general health. We need today in India is an Oral Health Revolution similar to the Green Revolution and White Revolution”.

Shri Pranab Mukherjee
Hon’ble President of India

PSM India Capsules
PSM INDIA’s founder, Mr. Bejon Misra addresses PSM's 5th annual conference
On 18th September 2014, Founder of PSM India Mr. Bejon Misra participated at the 5th Interchange held at the Knight Conference Center at The Newseum, 555 Pennsylvania Av., NW, Washington DC. It was a unique opportunity for Mr. Misra because he was one of the few amongst the participants who had the privilege to attend all the 5 Interchange organised since 2010. For the first time PSM China was also present, represented by Madame LiHong Gu. Mr Misra shared the success story of PSM in India since it got started in 2010 and narrated how the challenges were met and the partnership now is considered as a unified voice of the various stakeholders in the pharma supply chain in India. The present focus of PSM India is to empower the consumers to demand safe and quality medicines and ensure they are accessible to the patients at the time of their need. He also explained to the participants how the Government of India supported the various initiatives like reporting of adverse drug reactions in the toll free helpline number 1800-11-4424 and also the website It is noteworthy that within 5 years PSM India has got recognised by the various players in the pharma supply chain as a strong link between the Governments and the end users/patients.
Read More

We are pleased to inform that the Board of Jury of Partnership for Safe Medicines India for the selection of THE BEST PHARMACIST AWARD has shortlisted 4 pharmacists across India. Heartiest Congratulations to the award winners……

Paramathma Chilukuri, Nalgonda
Ratnadeep Kurtarkar, Goa
Mahadev Patel, Mulund
Deepak Barai, Thane

For more details click here

National Injections
Three officials suspended for certifying drug as 'qualified' Bengaluru, Sept 2014: The State Drugs Controller has recommended suspension of three officials – Junior Science Officer, Government Analyst and Chief Scientific Officer – for allegedly certifying a drug as ‘qualified’ despite negative report in the test and analysis. Health and Family Welfare Department Principal Secretary N Sivasailam has submitted before Upalokayukta that the case will be entrusted to Lokayukta for disciplinary enquiry as per service rules. Read More
Gujarat FDCA act against 1400 chemists for not having pharmacists out of 7000 shops in state Mumbai, Sept, 2014: In a massive drive aimed at checking the presence of pharmacists in retail chemists shops, Gujarat Food and Drug Control Administration (FDCA) has till now scoured around 7000 plus chemists shops across Gujarat. Following the ongoing probe, the state drug regulatory body has already busted around 1400 chemists shops found to be flouting the rules and regulations of the Drugs and Cosmetics Act that requires presence of pharmacists in the chemist shops. Read More
46 patients react to antibiotic shot in PhulbaniBERHAMPUR, Sept 2014: Forty-six patients suffered serious reactions to an antibiotic shot at the district headquarters hospital at Phulbani in Kandhamal district late on Sunday. The patients admitted to Phulbani hospital were undergoing treatment for fever, typhoid, malaria and other seasonal infections. The adverse effect started soon after they were injected with Edicef-SB, an antibiotic commonly used for bacterial diseases and during post-operation period. While some patients complained of head-reeling and vomiting, others ran high fever. Read More
Drug Laws & Policy Injections
Health Ministry to conduct all India survey on extent of availability of spurious drugs Mumbai, Sept 2014: The Union health ministry will soon conduct an all India survey on the extent of availability of spurious and not-of-standard quality drugs in the country. It will be a broad-based survey in which around 42,000 samples would be drawn from across the country which would include 15 therapeutic categories of drugs which is listed in National List of Essential Medicines (NLEM), 2011. Read More
IPC enters into MoU with NACO to monitor ADRs of drugs covered under NACP Mumbai, September, 2014: The Indian Pharmacopoeia Commission (IPC) recently entered into a Memorandum of Understanding (MoU) with the National AIDS Control Organisation (NACO) in Delhi for setting up systems and processes for reporting, analysis and monitoring of adverse drug reactions arising due to use of anti-retroviral (ARV) medicines in the programme. Read More
Pharma Injections
Ayurveda and Diabetes Mumbai, September, 2014: Glucose comes from the food we eat and is also made in liver and muscles. The blood carries glucose to all the cells in our body.
Diabetes Mellitus is a chronic metabolic disorder in which the body is unable to make proper use of glucose, resulting in the condition of hyperglycaemia (high blood sugar). Excess glucose in the blood ultimately results in high levels of glucose being present in the urine (glycosuria). This increases the urine output, which leads to dehydration and increased thirst.
Read More
Multi-drug HIV shield for infants- Doctors trained on new treatment regimen Ranchi, Sept. 2014: Committed to eliminating HIV infections among children by 2015, Jharkhand State AIDS Control Society (JSACS) today took the major decision of starting from October a multi-drug anti-retroviral regimen to prevent parent-to-child transmission of the virus. Read More

Artificial Sweeteners Linked to Glucose Intolerance

Sept 2014: The artificial sweeteners aspartame, sucralose, and saccharin cause blood glucose abnormalities in mice and some humans, a team reports in an article published online September 17 in Nature. The changes in glucose tolerance seem to be driven by the microbiome and can be reproduced in germ-free mice by giving them gut microbes from a person who has consumed the sweeteners. Read More

Regulatory experts push for pharma companies to strengthen data integrity

Mumbai, Sept 2014: Regulatory experts stressed that the Indian pharma cos should put special focus on following all the data integrity requirements to avoid crackdown by regulatory agencies. This warning comes in the wake of growing incidence of issuance of letters by the US FDA and other regulatory heads to Indian pharma cos for having data integrity issues, where inspectors have discovered glaring problems in the files. Data integrity issues have become a mounting problem for the Indian pharma companies in the recent past as many like Sun Pharmaceutical have come under scan for flouting data integrity regulations. Ranbaxy, Canton Laboratories, USV Limited, Wockhardt Limited, Agila Specialties, Posh Chemicals, Aarti Drugs, Fresenius Kabi Oncology, RPG Life Sciences etc were also in the recent past issued warning letters for having incomplete records and lack of data integrity. Read More

Global Injections
Health Ministers commit to control and eliminate vector-borne diseases Dhaka, September, 2014: Health Ministers from WHO’s South-East Asia Region adopted the Dhaka Declaration on vector-borne diseases today. The Ministers from the Region’s 11 Member States met today at the Thirty-second Meeting of Ministers of Health ..... Read More
US marshals seize non-FDA approved drugs claiming to treat liver diseases Maryland, Sept 2014: US marshals have seized various unapproved injectable drug products from a New Jersey beauty company, including some that claimed to treat degenerative liver and brain diseases, alcoholic liver diseases, and scurvy, according to an FDA press release. Read More

Roche warns of fake MabThera in GermanySept, 2014: Roche has confirmed that counterfeit versions of its big-selling cancer and arthritis drug MabThera have been discovered in Germany. News that MabThera (rituximab; also sold as Rituxan) has been targeted by counterfeiters comes just a few months after the Swiss drug maker revealed that illicit, tampered copies of its breast cancer drug Herceptin (trastuzumab) were also circulating in the EU market after a theft in Italy.Read More

First UK volunteer gets experimental GSK Ebola shot in trialSeptember, 2014: The first volunteer in a fast-tracked British safety trial of an experimental Ebola vaccine made by GlaxoSmithKline received the injection on Wednesday, trial organizers said.Read More

Antibiotics R&D to get critical lift by executive order, Obama advisory groupSeptember , 2014: Antibiotics development is about to get a needed boost with the release of new federal proposals aimed at curbing rising antibacterial-resistant infections caused by so-called superbugs.Read More

Drug Dopes
DCGI approves EPIRUS' Remicade biosimilar to market in India Mumbai, September 2014: The Drug Controller General of India (DCGI) has approved marketing and manufacturing of Remicade (infliximab) bio similar BOW015 of EPIRUS Biopharmaceuticals, Inc., a Boston-based biopharmaceutical company focused on the global development and commercialization of bio similar monoclonal antibodies. BOW015 is the first infliximab bio similar approved in India. Read More
FDA approves Movantik for opioid-induced constipation September 2014: The U.S. Food and Drug Administration approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain. Read More

FDA approves Lilly's diabetes drug Trulicity

September 2014: The US Food and Drug Administration has approved dulaglutide, Eli Lilly’s once-weekly glucagon-like peptide-1 receptor agonist for type 2 diabetes, to be marketed as Trulicity.. Read More

Mylan recalls nitro-glycerine spray due to defective pump

Otawa, Sept 2014: Mylan Pharmaceuticals ULC Canada, in consultation with Health Canada, is voluntarily recalling all lots of its Mylan-Nitro Spray 0.4 mg/metered dose due to the product missing the "dip tube," which is part of the pump component. Read More

FDA Approves Contrave (bupropion/naltrexone) for Weight Management

September 2014: The U.S. Food and Drug Administration today approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. Read More

Upcoming Events
UpComing Events
Click Here For More Events

The Partnership for Safe Medicines offers valuable information on “What kind business are fake online pharmacies” to teach consumers how to safely order prescription drugs over the Internet.


Read More

Frequently Asked Questions Q1. What do you mean by OTC Drugs?
Answer: OTC or over-the-counter Drugs are which can be bought by a consumer without prescription from a healthcare professional. Such medicines are available at pharmacy, drug store or sometimes also in local grocery, supermarkets. As a general rule, over-the-counter drugs have to be used primarily to treat a condition that does not require the direct supervision of a doctor and must be proven to be reasonably safe and well tolerated. They are generally used for common ailments or day-to-day problems like to relieve pain, itches, indigestion, constipation, nausea, skin problems, tooth decay, athlete's foot, wounds, migraines and most commonly symptoms of a cold or flu (influenza).

Q2. Is it safe to consume too much of OTC medications?
Answer:Though Medicines are allowed to be sold over-the-counter only after the approval from regulatory authority but still they are not beyond any risk. Some interact with other medicines, supplements, foods or drinks. Others cause problems for people with certain medical conditions. They are generally not safe during conditions of pregnancy, lactation, vulnerable patients of ulcer, diabetes, hypertension, kidney and liver problems and especially for children.
Therefore PSM feels that it is important to take medicines correctly and in right dose and for correct time period. OTC medicines should not be taken in longer or in higher doses than the recommendation of the label. If there is persistent symptom or temporary relief from a disease condition, then it needs to take care of and consultation with doctor to stop further aggravation of any critical condition or adverse effect.

Laughter Dose
Blog Addicts
Activa lively people co-operative blogs : “PSM- India’s is putting a tough battle against menace of counterfeit medicines in India which is really praiseworthy!”
Dr. Anju (M. Pharm, PhD) says: ‘The newer version of PSM Newz- The Prescription is providing more of information and awareness’.
Arjun safe medicine foundation twits : ‘Spurious Drugs business should be treated as heinous crime and we support the noble fight for the cause of PSM India against such menace. ’
This Newsletter is brought to you by
© 2011 Partnership for Safe Medicines India
F-9, 2nd floor, Kailash Colony, New Delhi -110048;;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.